Clinical Trial Update: Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of long-acting cabotegravir in healthy adults completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Infection

Drugs mentioned

• Cabotegravir long-acting (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2020-06-22